Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-035507
Filing Date
2025-03-07
Accepted
2025-03-07 16:10:27
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atra-20241231.htm   iXBRL 10-K 3681618
2 EX-4.6 atra-ex4_6.htm EX-4.6 46440
3 EX-19.1 atra-ex19_1.htm EX-19.1 57166
4 EX-21.1 atra-ex21_1.htm EX-21.1 6086
5 EX-23.1 atra-ex23_1.htm EX-23.1 3507
6 EX-31.1 atra-ex31_1.htm EX-31.1 15335
7 EX-31.2 atra-ex31_2.htm EX-31.2 15214
8 EX-32.1 atra-ex32_1.htm EX-32.1 12646
9 EX-97.1 atra-ex97_1.htm EX-97.1 40255
10 GRAPHIC img121855242_0.jpg GRAPHIC 199185
  Complete submission text file 0000950170-25-035507.txt   14447101

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20241231.xsd EX-101.SCH 1854886
97 EXTRACTED XBRL INSTANCE DOCUMENT atra-20241231_htm.xml XML 2473841
Mailing Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320
Business Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320 805-623-4211
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36548 | Film No.: 25720159
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)